心血管手术器械市场按产品类型、应用、最终用户和材料划分－2025-2032年全球预测

预计到 2032 年，心血管手术器械市场规模将达到 4,098 亿美元，复合年增长率为 11.56%。

关键市场统计数据
基准年 2024	1707.8亿美元
预计年份：2025年	1909.6亿美元
预测年份 2032	4098亿美元
复合年增长率 (%)	11.56%

分析心血管手术器材市场格局，说明器材创新、临床需求和采购动态如何影响策略决策。

在器械创新、手术流程变革和供应链韧性等复杂因素的共同作用下，心血管手术器械生态系统日趋成熟。本执行摘要总结了当前的市场动态，并重点阐述了影响临床和商业策略的最重要发展。本文将技术进步置于不断变化的手术流程偏好、监管监督和材料科学进步的背景下进行分析，这些因素共同影响着采购、临床结果和供应商竞争。

临床医生持续要求医疗器材能够实现更高的精准度、更短的手术时间和更可预测的止血效果，而医院系统则优先考虑器械的耐用性、成本控制和库存合理化。因此，製造商正积极回应，推出模组化产品架构、先进的生物材料和整合式手术系统，旨在降低术中操作的复杂性。随着该领域的不断发展，临床、监管和製造领域的跨部门合作将决定哪些创新能够成为标准疗法，哪些只能作为辅助。本导言将探讨变革性转变、关税的影响、细分市场的具体考虑、区域动态、竞争定位、可操作的建议以及支持本检验的调查方法。

心胸外科器械研发、手术操作和供应链策略的关键变革将重新定义临床和商业性价值创造。

一系列变革性变化正在重塑心臟外科手术器械的临床实践和商业性模式。生物材料和合成移植物工程的进步提高了生物相容性和长期耐久性；电外科技术的改进和泵技术的提升减少了术中创伤并改善了灌注控制；而器械模组化和数位化整合的融合则实现了更智慧的器械选择和术中反馈迴路，为临床医生提供数据，以指导即时决策和术后品质评估。

同时，外科技术的不断发展，包括微创手术和混合手术的兴起，正在改变产品需求格局，推动对体积更小、适应性更强的器械和瓣膜解决方案的需求。供应链的韧性和生产的灵活性已成为市场参与企业的核心优先事项，促使他们投资建造区域製造中心并采用双源筹资策略。总而言之，这些转变正在重新定义买家的价值等式，为那些能够证明其产品能够经临床验证改善患者预后并具有可预测成本曲线的製造商创造了机会。

2025年关税政策的变化将如何推动心臟医疗设备生态系统的供应链重组、生产在地化以及整体拥有成本的重新评估？

2025年关税的实施将为全球采购流程带来显着的摩擦，迫使医院、手术网路和设备供应商重新评估筹资策略和成本分摊机制。关税的实施提高了本地生产和近岸外包的相对吸引力，加速了关于重组生产基地和供应商多元化的讨论。因此，采购团队正专注于整体拥有成本，包括关税、物流、库存持有成本以及供应商整合或替代对其营运的影响。

为此，一些製造商正在调整合约条款，并探索关税缓解策略，例如关税工程、关税分类审查以及提高生产本地化程度。这些措施旨在维持价格竞争力，同时确保供应可靠性。此外，关税环境促使人们重新关注产品合理化，迫使医疗服务提供者简化设备处方流程，并优先考虑可跨越不同适应症且不会大幅增加关税的多用途平台。这些因素累积作用，导致策略重点转变，更加重视供应链韧性、生产弹性以及在不断变化的贸易环境下展现可预测的成本结构。

深度细分智慧揭示产品类型、临床应用、最终用户环境和材料类别如何相互交织，从而驱动差异化需求。

基于细分市场的分析揭示了不同产品类型、临床应用、终端用户和材料类别之间的差异化需求模式和竞争动态。依产品类型划分，主动脉移植物分为两类：生物移植物，其重点在于与宿主整合；以及合成移植物，其重点在于长期耐用性。心肺体外迴圈系统在性能预期方面存在显着差异：离心式帮浦系统，其重点在于减少血液损伤；而滚压泵系统，其重点在于易用性和成本效益。电外科设备分为双极设备和单极设备，前者可提供高能量输出，后者则继续满足各种外科手术需求。外科缝合线和缝合钉包括用于临时伤口支撑的可吸收缝合线、永久性缝合的不可吸收缝合线以及用于快速闭合的缝合钉。血管闭合解决方案包括用于机械闭合的血管夹和用于辅助止血的血管密封剂。

主动脉瘤修復分为血管内修復和开放性手术，两者所需的器械各不相同。先天性心臟缺陷矫正强调器械的小型化和精准性，尤其适用于房间隔缺损（ASD）和室间隔缺损（VSD）的封堵手术。冠状动脉绕道手术手术（CABG）继续支援非体外循环和体外循环两种手术流程，每种流程都需要特定的器械。心臟瓣膜修復和置换强调主动脉瓣修復和二尖瓣修復所需的器械特性不同。终端使用者群体涵盖门诊手术中心、医院和专科诊所，每个机构都有其自身的采购週期、库存限制和临床吞吐量预期。材料分类—生物材料、金属材料和聚合物材料—影响着监管路径、灭菌通讯协定和使用者偏好。了解这些细分维度之间的交集对于协调产品开发、临床证据产生和商业性打入市场策略至关重要。

美洲、欧洲、中东和非洲以及亚太地区的区域动态和市场准入现状将影响临床应用和商业性成功。

区域动态对临床应用模式、监管路径和商业策略有显着影响。在美洲，需求主要受医院系统整合、对手术效率的重视以及支付方对临床和经济价值的严格审查所驱动。这种环境有利于那些兼具临床差异化优势、可预测的供应链和长期维护支援的医疗器材。欧洲、中东和非洲地区是一个异质性区域，既面临挑战也蕴藏着独特的机会，包括监管协调、医疗基础设施的多样性以及不断变化的报销政策。在这些市场取得成功往往取决于强大的本地伙伴关係和灵活的定价模式。在亚太地区，产能的快速扩张、对微创手术基础设施的投资以及对本土製造的日益重视，正在打造一个充满活力的市场，能够满足该地区独特临床需求和监管要求的灵活製造商将获得丰厚的回报。

这些区域差异需要量身定制的商业性策略，从临床证据生成策略到对经销伙伴和本地化生产的投资，都应如此。製造商若能产品系列与区域手术偏好相契合，并投资于监管专业知识和针对特定市场的临床医生互动，将更有利于在不同地区获取长期价值。

心血管手术器材製造商与专业创新者之间的竞争动态和策略伙伴关係推动了创新、市场进入和临床应用。

心臟外科器械市场的竞争格局由成熟的器材製造商、新兴的专业创新者以及加速临床检验和分销管道拓展的策略伙伴关係关係共同塑造。大型公司通常透过整合解决方案、丰富的产品系列以及对临床证据和上市后监测的持续投入来脱颖而出。同时，一些专注于特定领域的企业则倾向于利用专业技术解决特定手术中的痛点，例如用于复杂血管闭合的纯化密封剂或具有更佳操作性能的新一代缝合线，从而在临床上站稳脚跟。

策略联盟和收购对于整合技术能力和拓展地域覆盖范围仍然至关重要。医疗器材製造商与临床研究网路之间的合作有助于更快地产生证据并改善产品推广应用，而与契约製造製造商和物流供应商的合作则能增强供应链的韧性。儘管拥有强大临床资料集、可扩展生产能力和灵活商业模式的市场现有企业仍保持着明显的竞争优势，但能够在特定应用场景中展现出显着的流程优势和成本效益的创新企业，则能够迅速颠覆既有的市场格局。

针对产业领导者，聚焦临床证据、生产敏捷性、模组化平台和先进商业模式，提出切实可行的策略要务。

产业领导者应采取多管齐下的策略，将产品创新与临床工作流程整合、监管前瞻性和供应链韧性结合。首先，投资转化临床研究，将设备性能与诸如缩短手术时间、降低併发症发生率和改善患者康復轨迹等有意义的临床结果联繫起来。此类证据不仅支持临床应用，还能加强与支付方和医院系统基本契约谈判。其次，优先考虑灵活的製造地和近岸外包方案，以减轻关税和物流波动的影响，同时能够快速回应区域需求变化。第三，在设计产品平台时应考虑模组化，使一个核心系统能够应用于多种手术，从而简化机构投资者的采购和库存管理。

此外，透过有针对性的培训、基于模拟的入职培训和共用结果跟踪，深化​​与临床医生的伙伴关係，以增强用户信心并收集真实世界证据。最后，尽可能采用订阅或基于结果的定价模式，为购买者提供可预测的预算，并为製造商提供持续的收入来源。透过协调临床证据、生产灵活性和前瞻性的商业性策略，行业领导者可以在不断变化的市场中获得永续优势。

透过严谨的混合方法研究途径，结合临床医生访谈、监管调查和供应链分析，检验了临床和商业性的见解。

本分析的调查方法结合了定性和定量方法，以确保其全面性和平衡性。主要资料来源包括对心臟外科医生、医院采购负责人、临床工程师和製造企业高管的访谈，以获取关于器械性能、手术趋势和采购行为的第一手观点。此外，还对监管指南、临床试验报告和卫生技术评估报告进行了结构化审查，以支持临床和安全性的论述。

二次分析评估了公开的监管文件、产品概况和同行评审文献，以识别技术进步和材料性能特征。透过产业物流报告和供应商访谈评估了供应链和关税的影响，以了解其对采购和生产决策的实际意义。在整个过程中，跨资料来源的输入三角验证和交叉检验为趋势的可靠解读提供了支持，专家评审确保结论反映了当前的临床实践和商业性现实。

对技术创新、供应链韧性和区域差异进行综合分析，为心血管手术器械相关人员明确战略要务。

总之，心血管手术器械市场正处于曲折点，其驱动力来自材料创新、手术流程的改进以及贸易动态的演变。生物材料的改良、电外科和灌注技术的进步，以及微创和混合手术模式的兴起，正在不同产品类型和临床应用领域催生差异化的需求。关税相关的干扰凸显了生产地接近性和供应链弹性的策略重要性，促使企业重新评估筹资策略，并将整体拥有成本置于优先地位。区域差异进一步加剧了竞争格局的复杂性，凸显了製定在地化市场策略和深入了解监管法规的必要性。

未来，能够将强有力的临床证据与敏捷的生产製造和灵活的商业模式相结合的製造商，将更有能力满足从门诊手术中心到三级医院和专科诊所等各类终端用户的需求。与临床医生和供应链合作伙伴的策略合作将加速产品应用，并确保设备创新能为患者和医疗机构带来可衡量的益处。成功之路清晰可见：优先考虑具有临床意义的创新，建立稳健的供应链，并以结果为导向的价值主张吸引买家。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

• 快速整合病患特异性3D列印牵引与稳定装置以进行精准心血管手术
• 增加抗菌涂层微创手术钳的使用，以降低术后感染率
• 开发用于复杂开胸手术期间即时血流动力学分析的人工智慧灌注监测主机
• 三级医疗中心使用机器人辅助内视镜器械进行二尖瓣和三尖瓣修復手术的数量迅速增加
• 推出适用于混合手术室的腹腔镜工具包，以简化心血管手术和介入手术的联合手术。
• 监管核准挑战和报销政策变化影响下一代环状成形术环的市场进入
• 为农村心血管手术计画开发一个整合智慧器械手柄的远距教学平台
• 专为微创心血管组织修復应用而设计的生物可降解聚合物基缝合锚钉的出现

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章心血管手术器械市场（依产品类型划分）

• 主动脉移植
  • 生物移植
  • 合成接枝
• 心肺体外迴圈系统
  • 离心式帮浦系统
  • 滚筒帮浦系统
• 电外科设备
  • 双极元件
  • 单极仪器
• 心臟瓣膜
  • 机械阀
  • 组织瓣膜
• 外科缝合线和缝合钉
  • 可吸收缝线
  • 不可吸收缝线
  • 手术缝合钉
• 血管闭合装置
  • 血管夹
  • 血管密封剂

第九章心血管手术器械市场（依应用领域划分）

• 主动脉瘤修復
  • 血管内修復
  • 开放性手术
• 先天性心臟疾病矫正
  • ASD 闭合
  • 室间隔缺损封堵术
• 冠状动脉绕道手术手术
  • 非体外循环冠状动脉绕道手术
  • 体外循环冠状动脉绕道手术
• 心臟瓣膜修復和置换
  • 主动脉瓣修补
  • 二尖瓣修復

第十章心血管手术器械市场（依最终用户划分）

• 门诊手术中心
• 医院
• 专科诊所

第十一章心血管手术器械市场（依材料分类）

• 生物
• 金属系统
• 聚合物

第十二章 各地区心血管手术器械市场

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十三章心血管手术器械市场：依组别划分

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十四章 各国心血管手术器械市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十五章 竞争格局

• 2024年市占率分析
• FPNV定位矩阵，2024
• 竞争分析
  • Medtronic plc
  • Johnson & Johnson
  • Abbott Laboratories
  • Getinge AB
  • Terumo Corporation
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Edwards Lifesciences Corporation

The Cardiac Surgery Instruments Market is projected to grow by USD 409.80 billion at a CAGR of 11.56% by 2032.

KEY MARKET STATISTICS
Base Year [2024]	USD 170.78 billion
Estimated Year [2025]	USD 190.96 billion
Forecast Year [2032]	USD 409.80 billion
CAGR (%)	11.56%

An authoritative framing of the cardiac surgery instruments landscape that contextualizes device innovation, clinical demand, and procurement dynamics shaping strategic decisions

The cardiac surgery instruments ecosystem has matured into a complex interplay of device innovation, procedural change, and supply chain resilience. This executive summary synthesizes the prevailing market dynamics and draws attention to the most consequential developments shaping clinical practice and commercial strategy. It frames the technological progress in a context of evolving procedural preferences, regulatory oversight, and material science advancements that collectively influence procurement, clinical outcomes, and vendor competitiveness.

Clinicians continue to demand devices that afford greater precision, shorter procedural times, and predictable hemostasis, while hospital systems prioritize durability, cost-control, and inventory rationalization. Consequently, manufacturers are responding with modular product architectures, refined biomaterials, and integrated surgical systems that aim to lower intraoperative complexity. As the sector progresses, collaboration across clinical, regulatory, and manufacturing domains will determine which innovations become standards of care versus niche adjuncts. This introduction sets the stage for the subsequent sections, which examine transformative shifts, tariff impacts, segmentation-specific insights, regional dynamics, competitive positioning, actionable recommendations, and the methodological approach underpinning the analysis.

Critical transformative shifts in cardiothoracic device development, procedural practice, and supply chain strategies that are redefining clinical and commercial value creation

A series of transformative shifts is reshaping both clinical practice and commercial approaches in cardiac surgery instrumentation. Advances in biomaterials and synthetic graft engineering are improving biocompatibility and long-term durability, while electrosurgical refinement and enhanced pump technologies are reducing intraoperative trauma and improving perfusion control. Meanwhile, the convergence of device modularity and digital integration enables smarter instrument selection and intraoperative feedback loops, providing clinicians with data that can inform real-time decisions and post-procedural quality assessments.

Concurrently, procedural evolution such as increased uptake of minimally invasive and hybrid approaches is altering product demand profiles, with enhanced demand for smaller footprint devices and adaptable valve solutions. Supply chain resilience and manufacturing agility have become central priorities for market participants, prompting investment in regional manufacturing hubs and dual-sourcing strategies. Collectively, these shifts are redefining the value equation for purchasers and creating opportunities for manufacturers that can demonstrate clinically substantiated improvements in outcomes alongside predictable cost curves.

How 2025 tariff policy shifts are compelling supply chain realignment, manufacturing localization, and total cost of ownership reassessments across the cardiac devices ecosystem

The introduction of tariffs in 2025 has introduced notable friction into global procurement flows, compelling hospitals, surgical networks, and device vendors to reassess sourcing strategies and cost allocation mechanisms. Tariff measures have increased the comparative attractiveness of local manufacturing and nearshoring, accelerating conversations about production footprint realignment and supplier diversification. As a result, procurement teams are emphasizing total cost of ownership considerations, including duties, logistics, inventory holding costs, and the operational impacts of supplier consolidation or substitution.

In response, several manufacturers have adjusted contractual terms and explored tariff-mitigation tactics such as tariff engineering, tariff classification reviews, and increased manufacturing localization. These approaches aim to preserve competitive pricing while maintaining supply reliability. Additionally, the tariff environment has stimulated renewed focus on product rationalization, compelling healthcare providers to streamline device formularies and prioritize multi-use platforms that can span procedural indications without incurring significant incremental duty exposure. The cumulative effect has been a reshuffling of strategic priorities that favors supply chain resilience, manufacturing flexibility, and the capacity to demonstrate predictable cost structures under changing trade regimes.

Deep segmentation intelligence revealing how product types, clinical applications, end-user settings, and material classes intersect to drive differentiated demand

Segmentation-driven insights reveal differentiated demand patterns and competitive dynamics across product types, clinical applications, end users, and material classes. Within product typologies, aortic grafts exhibit bifurcated requirements between biological grafts that prioritize host integration and synthetic grafts that emphasize long-term durability; cardiopulmonary bypass systems are marked by divergent performance expectations between centrifugal pump systems, prized for reduced blood trauma, and roller pump systems, valued for familiarity and cost-effectiveness. Electrosurgical devices separate into bipolar devices that offer focused energy delivery and monopolar devices that continue to serve broad surgical needs. Heart valves present a clear split between mechanical valves that deliver exceptional longevity and tissue valves that address anticoagulation concerns, while surgical sutures and staples cover absorbable sutures for transient wound support, non-absorbable sutures for permanent approximation, and staples for rapid closure. Vessel closure solutions span vascular clips for mechanical occlusion and vascular sealants for adjunct hemostasis.

Application-based distinctions further refine demand: aortic aneurysm repair differentiates endovascular repair from open surgery with distinct device profiles; congenital heart defect correction emphasizes device miniaturization and precision in ASD closure and VSD closure; coronary artery bypass grafting continues to support both off-pump CABG and on-pump CABG workflows, each dictating specific instrumentation; heart valve repair and replacement segments highlight different device attributes for aortic valve repair versus mitral valve repair. End user segmentation illustrates deployment contexts across ambulatory surgical centers, hospitals, and specialty clinics, each with unique procurement cycles, inventory constraints, and clinical throughput expectations. Material classification-biological products, metal instruments, and polymer instruments-shapes regulatory pathways, sterilization protocols, and user preferences. Understanding how these segmentation axes intersect is essential for tailoring product development, clinical evidence generation, and commercial go-to-market strategies.

Regional dynamics and market access realities across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine clinical uptake and commercial success

Regional dynamics exert a profound influence on clinical adoption patterns, regulatory pathways, and commercial strategy. In the Americas, demand is driven by consolidated hospital systems, a focus on procedural efficiency, and payer scrutiny that rewards demonstrable clinical and economic value. This environment favors devices that combine clinical differentiation with predictable supply chains and long-term maintenance support. The Europe, Middle East & Africa region presents a heterogeneous landscape where regulatory harmonization, variable healthcare infrastructure, and evolving reimbursement policies create both challenges and niche opportunities; success in these markets is often predicated on strong local partnerships and adaptive pricing models. Across Asia-Pacific, rapid capacity expansion, investments in minimally invasive surgery infrastructure, and a growing focus on domestic manufacturing create a dynamic market that rewards agile manufacturers capable of addressing localized clinical needs and regulatory requirements.

These regional nuances require tailored commercial approaches, from clinical evidence generation strategies to distribution partnerships and localized manufacturing investments. Manufacturers that align product portfolios with regional procedural preferences and that invest in regulatory expertise and market-specific clinician engagement will be better positioned to capture long-term value in diverse geographies.

Competitive dynamics and strategic partnerships driving innovation, market entry, and clinical adoption across cardiac surgery device manufacturers and specialty innovators

Competitive landscapes in cardiac surgery instruments are shaped by a mix of established device manufacturers, emerging specialized innovators, and strategic partnerships that accelerate clinical validation and distribution reach. Leading firms typically differentiate through integrated solutions, broad product portfolios, and sustained investments in clinical evidence and post-market surveillance. Meanwhile, niche players frequently secure clinical footholds by addressing specific procedural pain points with focused technologies-such as refined sealants for complex vascular closures or next-generation sutures that improve handling characteristics.

Strategic alliances and acquisitions continue to be pivotal in consolidating technological capabilities and expanding geographic reach. Collaboration between device makers and clinical research networks facilitates faster evidence generation and improved adoption curves, while partnerships with contract manufacturers and logistics providers enhance supply chain resilience. Market incumbents that combine robust clinical datasets, scalable manufacturing, and flexible commercial models maintain distinct competitive advantages, though innovators that can demonstrate clear procedural benefits and cost-effectiveness in targeted use cases can rapidly disrupt established patterns.

Actionable strategic imperatives for industry leaders focusing on clinical evidence, manufacturing agility, modular platforms, and progressive commercial models

Industry leaders should pursue a multifaceted strategy that aligns product innovation with clinical workflow integration, regulatory foresight, and supply chain resilience. First, invest in translational clinical research that ties device performance to meaningful outcomes such as reduced operative time, lower complication rates, and improved patient recovery trajectories. Such evidence not only supports clinical adoption but also strengthens value-based contracting conversations with payers and hospital systems. Second, prioritize flexible manufacturing footprints and nearshoring options to mitigate tariff impacts and logistic volatility while enabling faster responsiveness to local demand shifts. Third, design product platforms with modularity in mind so that a single core system can be adapted across multiple procedures, thereby simplifying procurement and inventory management for institutional customers.

Additionally, cultivate deeper clinician partnerships through targeted training, simulation-based onboarding, and shared outcomes tracking to accelerate user confidence and to collect real-world evidence. Finally, adopt commercial models that allow for subscription or outcome-based pricing where feasible, offering predictable budgets for purchasers and recurring revenue streams for manufacturers. By synchronizing clinical evidence, manufacturing agility, and progressive commercial approaches, industry leaders can secure sustainable advantages in an evolving market.

A rigorous mixed-methods research approach combining clinician interviews, regulatory review, and supply chain analysis to validate clinical and commercial insights

The research methodology underpinning this analysis combined qualitative and quantitative approaches to ensure comprehensive validity and balanced interpretation. Primary inputs included interviews with practicing cardiac surgeons, hospital procurement leaders, clinical engineers, and senior executives within manufacturing organizations to capture firsthand perspectives on device performance, procedural trends, and buying behaviors. These insights were complemented by a structured review of regulatory guidances, clinical trial publications, and health technology assessments to corroborate clinical and safety narratives.

Secondary analysis evaluated publicly available regulatory filings, product dossiers, and peer-reviewed literature to map technological advancements and material performance characteristics. Supply chain and tariff implications were assessed through industry logistics reports and supplier interviews to understand practical impacts on sourcing and manufacturing decisions. Throughout, triangulation of inputs and cross-validation between data sources supported a robust interpretation of trends, while expert review ensured that the conclusions reflect current clinical practice and commercial realities.

Concluding synthesis of innovation, supply chain resilience, and regional nuances that define strategic imperatives for cardiac surgery instrument stakeholders

In conclusion, the cardiac surgery instruments landscape is at an inflection point driven by material innovation, procedural evolution, and evolving trade dynamics. The convergence of improved biomaterials, refined electrosurgical and perfusion technologies, and a shift toward minimally invasive and hybrid procedures is creating differentiated demand across product categories and clinical applications. Tariff-related disruptions have elevated the strategic importance of manufacturing proximity and supply chain flexibility, prompting organizations to reassess sourcing strategies and to prioritize total cost of ownership. Regional variations further complicate the competitive calculus, underscoring the need for localized go-to-market strategies and regulatory acumen.

Looking ahead, manufacturers that pair compelling clinical evidence with agile manufacturing and adaptive commercial models will be best positioned to meet the needs of diverse end users-from ambulatory surgical centers to tertiary hospitals and specialty clinics. Strategic collaboration with clinicians and supply chain partners will accelerate adoption and ensure that device innovation translates into measurable patient and operational benefits. The pathways to success are clear: prioritize clinically meaningful innovation, build resilient supply chains, and engage purchasers with outcome-oriented value propositions.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Rapid integration of 3D-printed patient-specific retraction and stabilization devices for precision cardiac surgery
• 5.2. Increasing adoption of antimicrobial-coated minimally invasive forceps to reduce postoperative infection rates in procedures
• 5.3. Development of AI-powered perfusion monitoring consoles for real-time hemodynamic analysis during complex open-heart operations
• 5.4. Surge in the use of robotic-assisted endoscopic instruments for mitral and tricuspid valve repair in tertiary care centers
• 5.5. Deployment of hybrid operating room-compatible laparoscopic toolsets to streamline combined cardiac and interventional procedures
• 5.6. Regulatory clearance challenges and reimbursement shifts shaping market access for next-generation annuloplasty rings
• 5.7. Growth of tele-mentoring platforms integrated with smart instrument handles for remote guidance in rural cardiac surgery programs
• 5.8. Emergence of biodegradable polymer-based suture anchors designed for minimally invasive cardiovascular tissue repair applications

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cardiac Surgery Instruments Market, by Product Type

• 8.1. Aortic Grafts
  • 8.1.1. Biological Grafts
  • 8.1.2. Synthetic Grafts
• 8.2. Cardiopulmonary Bypass Systems
  • 8.2.1. Centrifugal Pump Systems
  • 8.2.2. Roller Pump Systems
• 8.3. Electrosurgical Devices
  • 8.3.1. Bipolar Devices
  • 8.3.2. Monopolar Devices
• 8.4. Heart Valves
  • 8.4.1. Mechanical Valves
  • 8.4.2. Tissue Valves
• 8.5. Surgical Sutures And Staples
  • 8.5.1. Absorbable Sutures
  • 8.5.2. Non-Absorbable Sutures
  • 8.5.3. Surgical Staples
• 8.6. Vessel Closure Devices
  • 8.6.1. Vascular Clips
  • 8.6.2. Vascular Sealants

9. Cardiac Surgery Instruments Market, by Application

• 9.1. Aortic Aneurysm Repair
  • 9.1.1. Endovascular Repair
  • 9.1.2. Open Surgery
• 9.2. Congenital Heart Defect Correction
  • 9.2.1. ASD Closure
  • 9.2.2. VSD Closure
• 9.3. Coronary Artery Bypass Grafting
  • 9.3.1. Off-Pump CABG
  • 9.3.2. On-Pump CABG
• 9.4. Heart Valve Repair And Replacement
  • 9.4.1. Aortic Valve Repair
  • 9.4.2. Mitral Valve Repair

10. Cardiac Surgery Instruments Market, by End User

• 10.1. Ambulatory Surgical Centers
• 10.2. Hospitals
• 10.3. Specialty Clinics

11. Cardiac Surgery Instruments Market, by Material

• 11.1. Biological Products
• 11.2. Metal Instruments
• 11.3. Polymer Instruments

12. Cardiac Surgery Instruments Market, by Region

• 12.1. Americas
  • 12.1.1. North America
  • 12.1.2. Latin America
• 12.2. Europe, Middle East & Africa
  • 12.2.1. Europe
  • 12.2.2. Middle East
  • 12.2.3. Africa
• 12.3. Asia-Pacific

13. Cardiac Surgery Instruments Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Cardiac Surgery Instruments Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2024
• 15.2. FPNV Positioning Matrix, 2024
• 15.3. Competitive Analysis
  • 15.3.1. Medtronic plc
  • 15.3.2. Johnson & Johnson
  • 15.3.3. Abbott Laboratories
  • 15.3.4. Getinge AB
  • 15.3.5. Terumo Corporation
  • 15.3.6. Stryker Corporation
  • 15.3.7. Zimmer Biomet Holdings, Inc.
  • 15.3.8. B. Braun Melsungen AG
  • 15.3.9. Baxter International Inc.
  • 15.3.10. Edwards Lifesciences Corporation

LIST OF FIGURES

• FIGURE 1. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 11. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. NORTH AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 13. LATIN AMERICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. EUROPE, MIDDLE EAST & AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. EUROPE CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. MIDDLE EAST CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. AFRICA CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. ASEAN CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. GCC CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. EUROPEAN UNION CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. BRICS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. G7 CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. NATO CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. CARDIAC SURGERY INSTRUMENTS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 28. CARDIAC SURGERY INSTRUMENTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. CARDIAC SURGERY INSTRUMENTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL GRAFTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL GRAFTS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SYNTHETIC GRAFTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SYNTHETIC GRAFTS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SYNTHETIC GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SYNTHETIC GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SYNTHETIC GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SYNTHETIC GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CENTRIFUGAL PUMP SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CENTRIFUGAL PUMP SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CENTRIFUGAL PUMP SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CENTRIFUGAL PUMP SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CENTRIFUGAL PUMP SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CENTRIFUGAL PUMP SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ROLLER PUMP SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ROLLER PUMP SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ROLLER PUMP SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ROLLER PUMP SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ROLLER PUMP SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ROLLER PUMP SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIPOLAR DEVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIPOLAR DEVICES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIPOLAR DEVICES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIPOLAR DEVICES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIPOLAR DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIPOLAR DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MONOPOLAR DEVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MONOPOLAR DEVICES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MONOPOLAR DEVICES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MONOPOLAR DEVICES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MONOPOLAR DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MONOPOLAR DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MECHANICAL VALVES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MECHANICAL VALVES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MECHANICAL VALVES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MECHANICAL VALVES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MECHANICAL VALVES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MECHANICAL VALVES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY TISSUE VALVES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY TISSUE VALVES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY TISSUE VALVES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY TISSUE VALVES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY TISSUE VALVES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY TISSUE VALVES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ABSORBABLE SUTURES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ABSORBABLE SUTURES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ABSORBABLE SUTURES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ABSORBABLE SUTURES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ABSORBABLE SUTURES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ABSORBABLE SUTURES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY NON-ABSORBABLE SUTURES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY NON-ABSORBABLE SUTURES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY NON-ABSORBABLE SUTURES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY NON-ABSORBABLE SUTURES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY NON-ABSORBABLE SUTURES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY NON-ABSORBABLE SUTURES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL STAPLES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL STAPLES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL STAPLES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL STAPLES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL STAPLES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL STAPLES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR CLIPS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR CLIPS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR CLIPS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR CLIPS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR CLIPS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR CLIPS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 127. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR SEALANTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 128. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR SEALANTS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 129. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR SEALANTS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 130. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR SEALANTS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 131. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR SEALANTS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 132. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VASCULAR SEALANTS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 133. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 134. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 135. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, 2018-2024 (USD MILLION)
• TABLE 136. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, 2025-2032 (USD MILLION)
• TABLE 137. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, BY REGION, 2018-2024 (USD MILLION)
• TABLE 138. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, BY REGION, 2025-2032 (USD MILLION)
• TABLE 139. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 140. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 141. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 142. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 143. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ENDOVASCULAR REPAIR, BY REGION, 2018-2024 (USD MILLION)
• TABLE 144. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ENDOVASCULAR REPAIR, BY REGION, 2025-2032 (USD MILLION)
• TABLE 145. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ENDOVASCULAR REPAIR, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 146. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ENDOVASCULAR REPAIR, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 147. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ENDOVASCULAR REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 148. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ENDOVASCULAR REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 149. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 150. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OPEN SURGERY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 151. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 152. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 153. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 154. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 155. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, 2018-2024 (USD MILLION)
• TABLE 156. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, 2025-2032 (USD MILLION)
• TABLE 157. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 158. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 159. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 160. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 161. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 162. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 163. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ASD CLOSURE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 164. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ASD CLOSURE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 165. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ASD CLOSURE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 166. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ASD CLOSURE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 167. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ASD CLOSURE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 168. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ASD CLOSURE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 169. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VSD CLOSURE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 170. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VSD CLOSURE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 171. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VSD CLOSURE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 172. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VSD CLOSURE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 173. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VSD CLOSURE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 174. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VSD CLOSURE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 175. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2024 (USD MILLION)
• TABLE 176. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2025-2032 (USD MILLION)
• TABLE 177. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 178. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 179. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 180. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 181. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 182. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 183. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OFF-PUMP CABG, BY REGION, 2018-2024 (USD MILLION)
• TABLE 184. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OFF-PUMP CABG, BY REGION, 2025-2032 (USD MILLION)
• TABLE 185. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OFF-PUMP CABG, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 186. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OFF-PUMP CABG, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 187. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OFF-PUMP CABG, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 188. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY OFF-PUMP CABG, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 189. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ON-PUMP CABG, BY REGION, 2018-2024 (USD MILLION)
• TABLE 190. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ON-PUMP CABG, BY REGION, 2025-2032 (USD MILLION)
• TABLE 191. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ON-PUMP CABG, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 192. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ON-PUMP CABG, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 193. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ON-PUMP CABG, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 194. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ON-PUMP CABG, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 195. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, 2018-2024 (USD MILLION)
• TABLE 196. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, 2025-2032 (USD MILLION)
• TABLE 197. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 198. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 199. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 200. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 201. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 202. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 203. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC VALVE REPAIR, BY REGION, 2018-2024 (USD MILLION)
• TABLE 204. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC VALVE REPAIR, BY REGION, 2025-2032 (USD MILLION)
• TABLE 205. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC VALVE REPAIR, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 206. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC VALVE REPAIR, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 207. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC VALVE REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 208. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC VALVE REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 209. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MITRAL VALVE REPAIR, BY REGION, 2018-2024 (USD MILLION)
• TABLE 210. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MITRAL VALVE REPAIR, BY REGION, 2025-2032 (USD MILLION)
• TABLE 211. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MITRAL VALVE REPAIR, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 212. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MITRAL VALVE REPAIR, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 213. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MITRAL VALVE REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 214. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MITRAL VALVE REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 215. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 216. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 217. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 218. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 219. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 220. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 221. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 222. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 223. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 224. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 225. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 226. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 227. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 228. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 229. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 230. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 231. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 232. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 233. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 234. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 235. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
• TABLE 236. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
• TABLE 237. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 238. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL PRODUCTS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 239. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL PRODUCTS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 240. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL PRODUCTS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 241. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL PRODUCTS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 242. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY BIOLOGICAL PRODUCTS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 243. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY METAL INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 244. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY METAL INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 245. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY METAL INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 246. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY METAL INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 247. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY METAL INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 248. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY METAL INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 249. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY POLYMER INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 250. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY POLYMER INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 251. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY POLYMER INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 252. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY POLYMER INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 253. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY POLYMER INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 254. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY POLYMER INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 255. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 256. GLOBAL CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 257. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 258. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 259. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 260. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 261. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, 2018-2024 (USD MILLION)
• TABLE 262. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC GRAFTS, 2025-2032 (USD MILLION)
• TABLE 263. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2024 (USD MILLION)
• TABLE 264. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2025-2032 (USD MILLION)
• TABLE 265. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2018-2024 (USD MILLION)
• TABLE 266. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2025-2032 (USD MILLION)
• TABLE 267. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, 2018-2024 (USD MILLION)
• TABLE 268. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVES, 2025-2032 (USD MILLION)
• TABLE 269. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, 2018-2024 (USD MILLION)
• TABLE 270. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY SURGICAL SUTURES AND STAPLES, 2025-2032 (USD MILLION)
• TABLE 271. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, 2018-2024 (USD MILLION)
• TABLE 272. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY VESSEL CLOSURE DEVICES, 2025-2032 (USD MILLION)
• TABLE 273. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 274. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 275. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, 2018-2024 (USD MILLION)
• TABLE 276. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY AORTIC ANEURYSM REPAIR, 2025-2032 (USD MILLION)
• TABLE 277. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, 2018-2024 (USD MILLION)
• TABLE 278. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, 2025-2032 (USD MILLION)
• TABLE 279. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2018-2024 (USD MILLION)
• TABLE 280. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY CORONARY ARTERY BYPASS GRAFTING, 2025-2032 (USD MILLION)
• TABLE 281. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, 2018-2024 (USD MILLION)
• TABLE 282. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY HEART VALVE REPAIR AND REPLACEMENT, 2025-2032 (USD MILLION)
• TABLE 283. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 284. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 285. AMERICAS CARDIAC SURGERY INSTRUMENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD